Originalarbeiten (Autoren des NZN unterstrichen)
Five cases of Kaposi´s sarcoma in kidney graft recipients: possible
influence of the immunosuppressive therapy.
Kliem, V., Boeck, A, Eisenberger, U., Petersen, R., Radermacher, J., Hiß,
M., Pethig, M., Koch, K.M., Nashan, B., Brunkhorst, R.:
Treatment of chronic renal allograft failure by addition of mycophenolate
mofetil: Single-center experience in 40 patients.
Eberhard, O.K., Pötschik, H., Neumann, K.H., Kliem, V., Brunkhorst, R.:
Short- and long-term effects of fish oil on proteinuria, morphology and
renal hemodynamics in the Milan normotensive rat model of spontaneous
Kidney Blood Press. Res. 22: 128-134, 1999
Kliem, V., Radermacher, J., Hiß, M., Pethig, M., Burg, M., Brunkhorst, R.:
Conversion to tacrolimus for of acute corticosteroid- and antibody-
resistant rejection following kidney transplantation.
Transplant. Proc. 31 (Suppl. 7A): 37S-40S, 1999
Neumayer, H.-H., Paradis, K., Korn, A., Jean, C., Fritsche, L., Budde, K.,
Winkler, M., Kliem, V., Pichlmayr, R., Hauser, I.A., Burkhardt, K., Lison,
A.-E., Barndt, I., Appel-Dingemanse, S.:
Entry-into-human study with the novel immunosuppressant SDZ RAD in
Brit. J. Clin. Pharmacol. 48: 694-703, 1999
Widjaja, A., Kielstein, J.T., Horn, R., von zur Mühlen, A., Kliem, V.,
Free serum leptin but not bound leptin concentrations are elevated in
Nephrol. Dial. Transplant. 15: 846-850, 2000
Kliem, V., Burg, M., Radermacher, J., Hoffmann, M.W.,
Profound drop of cyclosporin A whole blood trough levels caused by St.
Lonnemann, G., Floege, J., Kliem, V., Brunkhorst, R., Koch, K.M.:
Extended daily veno-venous high-flux haemodialysis in patients with
acute renal failure and multiple organ dysfunction syndrome using a
Nephrol. Dial. Transplant. 15: 1189-1193, 2000
Kielstein, J., Termühlen, L., Sohn, J., Kliem, V.:
Minimal change nephrotic syndrome in a 65-year-old patient following
Küster, J., Kliem, V., Brunkhorst, R., Nashan, B., Oldhafer, K.,
Native pyeloureterostomy after kidney transplantation: experience in 48
Kliem, V., Tusch, G., Dannenberg, B., Brunkhorst, R.:
Renal transplantation in older adults - Is graft survival affected by age? A
Radermacher, J., Chavan, A., Schäffer, J., Stoess, B., Vitzthum, A.,
Kliem, V., Rademaker, J., Bleck, J., Gebel, M.J., Galanski, M.,
Detection of significant renal artery stenosis with color Doppler
sonography: combining extrarenal and intrarenal approaches to minimize
Pohanka, E., Bechstein, W.-O., Berlakovich, G., Binet, I., Friemann, S.,
Heemann, U., Kliem, V., Sperschneider, H., Stangl, M., Ringe, B.:
Dosierung und Monitoring von Tacrolimus in der Primärtherapie nach
Tillmann, H.L., Chen, D,-F., Trautwein, C., Kliem, V., Gundrey, A.,
Berning-Haag, A., Böker, K.H.W., Kubicka, S., Pastucha, L., Stangel, W.,
Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage
Bock, C.T., Buerke, B., Tillmann, H.L., Tacke, F., Kliem, V., Manns, M.P.,
Relevance of hepatitis B core gene deletions in patients after kidney
Vanrenterghem, Y., Ponticelli, C., Morales, J.M., Abramowicz, D.,
Baboolal, K., Eklund, B., Kliem, V., Legendre, C., Sarmento, A.L.M.,
Prevalence and management of anemia in renal transplant recipients: A
Brunkhorst, R., Lufft, V., Dannenberg, B., Kliem, V., Tusch, G., Pichlmayr,
Improved survival in patients with type 1 diabetes mellitus after renal
transplantation compared with hemodialysis: a case control study.
Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L.,
Jeffery, J., Kliem, V., Oppenheimer, F., Pohanka, E., Tufveson, G. on
behalf of the MOST International Study Group:
One-year post-transplant renal function is a strong predictor of long-term
kidney function: results from the Neoral®-MOST observational study.
Lebranchu, Y., Halimi, J.M., Bock, A., Chapman, J., Dussol, B., Fritsche,
L., Jeffery, J., Kliem, V., Oppenheimer, F., Pohanka, E., Salvadori, M.,
Tufveson, G. on behalf of the MOST International Study Group:
Delayed graft function: risk factors, consequences and parameters
affecting outcome - results from MOST, a multinational observational
Kliem, V., Fritsche, L., Haller, H., Suwelack, B., Abendroth, D., Fornara,
P., Pietruck, F., Frei, U., Donauer, J., Lison, A.E., Michel, U., Ulbricht, B.
Cyclosporine-based immunosuppressive strategies for kidney recipients -
interim analysis of german data from the multinational observational study
Burg, M., Kretzler, M., Banas, B., Gröne, H.J., Kliem, V.:
BK virus associated nephropathy in native kidneys of a heart allograft
Schmid, H., Nitschko, H., Gerth, J., Kliem, V., Henger, A., Cohen, C.D.,
Schlöndorff, D., Gröne, H.-J., Kretzler, M.:
Polyomavirus DNA and RNA detection in renal allograft biopsies:
results from a European multi-center study.
Salvadori, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V.,
Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., Rosati, A.,
Puig, X., Corbetta, G. on behalf of the MOST International Study Group:
Impact of mycophenolate mofetil dose posttransplantation on 12-month
renal function: analysis of the MOST database.
Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L.,
Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G.,
Bertoni, E. on behalf of the MOST International Study Group:
Estimated one-year glomerular filtration rate is the best predictor of long-
term graft function following renal transplant.
Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L.,
Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G.,
Bertoni, E. on behalf of the MOST International Study Group:
Low 1-year cyclosporine microemulsion doses are associated with better
5-year renal graft function: an insight from MOST, a multinational
Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y.,
Oppenheimer, F., Pohanka, E., Salvadori, M., Tufveson, G.:
Follow-up after renal transplantation with organs from donors after
Burg, M., Jäkel, D., Kiss, E., Kliem, V.:
Majocchi´s granuloma following kidney transplantation.
Tacrolimus in transplantation of the kidney. Communication 1.
Tacrolimus in transplantation of the kidney. Communication 2.
Nephrology (russian) 11 (4): 18-27, 2007
Tacrolimus in base immunosuppression after renal transplantation:
Nephrology (russian) 11 (4): 95-98, 2007
Frei, U., Noeldeke, J., Fabrizii, V., Arbogast, H., Margreiter, R., Fricke, L.,
Voiculescu, A., Kliem, V., Ebel, H., Albert, U., Lopau, K., Schnuelle, P.,
Nonnast-Daniel, B., Pietruck, F., Offermann, R., Persijn, G., Bernasconi,
Prospective age-matching in elderly kidney transplant recipients – a 5-
year analysis of the Eurotransplant senior program.
Kliem, V., Fricke, L., Wollbrink, T., Burg, M., Radermacher, J., Rohde, F.:
Improvement in long-term renal graft survival due to CMV prophylaxis
with oral ganciclovir: Results of a randomized clinical trial.
Kliem, V., Burg, M., Haller, H., Suwelack, B., Abendroth, D., Fritsche, L.,
Fornara, P., Pietruck, F., Frei, U., Donauer, J., Lison, A.E., Michel, U.:
Relationship of hepatitis B and C virus prevalences, risk factors, and
outcomes in renal transplant recipients: analysis of german data.
Canaud, B., Mingardi, G., Braun, J., Aljama, P., Kerr, P.G., Locatelli, F.,
Villa, G., van Vlem, B., McMahon, A.W., Kerloëguen, C., Beyer, U. and
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on
dialysis previously treated with darbepoetin alfa: results from STRIATA, a
Nephrol. Dial. Transplant. 23: 3654-3661, 2008
Fellström, B.C., Jardine, A.G., Schmieder, R.E., Holdass, H., Bannister,
K., Beutler, J., Chae, D.W., Chevaile, A.; Aurora Study Group:
Rosuvastatin and cardiovascular events in patients undergoing
Kliem, V., Michel, U., Burg, M., Bock, A., Chapman, J., Dussol, B.,
Fritsche, L., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Salvadori, M.,
Geographical prevalence, risk factors and impact of hepatitis B and
hepatitis C after renal transplantation.
Trappe, R., Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer,
H.H., Budde, K., Dreyling, M., Dührsen, U., Kliem, V., Schüttrumpf, S.,
Hauser, I.A., Mergenthaler, H.G., Schlattmann, P., Anagnostopoulos, I.,
Treatment of PTLD with rituximab and CHOP reduces the risk of renal
graft impairment after reduction of immunosuppression.
Weithofer, P., Schott, W., Bosse, A., Gröne, H.-J., Kliem, V.:
Nierenzellkarzinom: Ungewöhnliche Spätmetastasierung 14 und 23 Jahre
Dtsch. Med. Wochenschr. 134: 1674-1676, 2009
David, S., Kümpers, P., Lukasz, A., Fliser, D., Martens-Lobenhoffer, J.,
Bode-Böger, S., Kliem, V., Haller, H., Kielstein, J.:
Circulating angiopoietin-2 levels increase with progress of chronic kidney
Nephrol. Dial. Transplant. 25: 2571-2576, 2010
Maier, T., Schwarting, A., Mauer, D., Ross, R.S., Martens, A., Kliem, V.,
Wahl, J., Panning, M., Baumgarte, S., Müller, T., Pfefferle, S., Ebel, H.,
Tenner-Racz, K., Racz, P., Schmid, M., Strüber, M., Wolters, B.,
Gotthardt, D., Bitz, F., Frisch, L., Pfeiffer, N., Fickenscher, H., Sauer, P.,
Rupprecht, C.E., Roggendorf, M., Haverich, A., Galle, P., Hoyer, J.,
Management and outcomes after multiple corneal and solid organ
transplantations from a donor infected with rabies virus.
Lorenzen, J., Krämer, R., Kliem V., Bode-Böger, S.M., Veldink, H.,
Haller, H.H., Fliser, D., Kielstein, J.T.:
Circulating levels of osteopontin are closely related to glomerular filtration
rate and cardiovascular risk markers in patients with chronic kidney
Europ. J. Clin. Invest. 40: 294-300, 2010
Good, D.M., Zurbig, P., Argiles, A., Bauer, H.W., Behrens, G., Coon, J.J.,
Dakna, M., Decramer, S., Delles, C., Dominiczak, A.F., Ehrich, J.H.,
Eitner, F., Fliser, D., Frommberger, M., Ganser, A., Girolami, M.A.,
Golovko, I., Gwinner, W., Haubitz, M., Herget-Rosenthal, S., Jankowski,
J., Jahn, H., Jerums, G., Julian, B.A., Kellmann, M., Kliem, V., Kolch, W.,
Krolewski, A.S., Luppi, M., Massy, Z., Melter, M., Neususs, C., Novak, J.,
Peter, K., Rossing, K., Rupprecht, H., Schanstra, J.P., Schiffer, E.,
Stolzenburg, J.U., Tarnow, L., Theodorescu, D., Thongboonkerd, V.,
Vanholder, R., Weissinger, E.M., Mischak, H., Schmitt-Kopplin, P.:
Naturally occuring human urinary peptides for use in diagnosis of chronic
Mol. Cell. Proteomics 9: 2424-2437, 2010
Kielstein, J.T., Veldink, H., Martens-Lobenhoffer, J., Haller, H., Burg, M.,
Lorenzen, J., Lichtinghagen, R., Bode-Böger, S.M., Kliem, V.:
SDMA is an early marker of change of GFR after living related kidney
Nephrol. Dial. Transplant. 26: 324-328, 2011
Kielstein, J.T., Veldink, H., Martens-Lobenhoffer, J., Haller, H., Perthel,
R., Lovric, S., Lichtinghagen, R., Kliem, V., Bode-Böger, S.M.:
Unilateral nephrectomy causes an abrupt increase of inflammatory
mediators and a simultaneous decrease in plasm ADMA – a study in
Am. J. Physiol. Renal Pysiol. in press, 2011
Why balance my hormones?The purpose of Hormone Balancing Therapy (HBT) is to compensate for the hormones that you lost during normal aging, removal of the ovaries, or any other cause of decreased hormone production by the ovaries. HBT is more than treating menopausal symptoms. It is re-establishing hormone balance by taking the same hormones that your ovaries used to make. How are Nat
Sotilaslääketieteen Keskus Julkaisut vuonna 2007 A. Alkuperäisjulkaisut Anthoni SR, Rasinperä HA, Kotamies AJ, Komu HA, Pihlajamäki HK, Kolho K-L, Järvelä IE. Molecularly defined adult-type hypolactasia among working age people with reference to milk consumption and gastrointestinal symptoms. World J Gastroenterol 2007;13:1230-5 Elonheimo H, Niemelä S, Parkkola K, Multimäki